Corbus Pharmaceuticals Holdings (CRBP) Cash & Equivalents (QoQ) (2013 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) Cash & Equivalents (QoQ) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 112.73 Mn | 84.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.50% |
| Sep 30, 2025 | 27.15% |
| Jun 30, 2025 | 751.13% |
| Mar 31, 2025 | -80.62% |
| Dec 31, 2024 | -37.44% |
| Sep 30, 2024 | -18.00% |
| Jun 30, 2024 | 158.97% |
| Mar 31, 2024 | -33.36% |
| Dec 31, 2023 | 48.32% |
| Sep 30, 2023 | 435.19% |
| Jun 30, 2023 | -40.32% |
| Mar 31, 2023 | -82.96% |
| Dec 31, 2022 | 36.64% |
| Sep 30, 2022 | 212.02% |
| Jun 30, 2022 | -69.19% |
| Mar 31, 2022 | -48.25% |
| Dec 31, 2021 | -32.63% |
| Sep 30, 2021 | 862.05% |
| Jun 30, 2021 | -94.21% |
| Mar 31, 2021 | 5,278.06% |